AuthorisedHuman Pharmacology (Phase I)- First administration to humansMature B-Cell Neoplasm,
Non-Hodgkin Lymphoma,
Diffuse large B-cell lymphoma (DLBCL),
Waldenstrom Macroglobulinemia,
MALT Lymphoma,
Follicular Lymphoma,
Pediatric-Type Follicular Lymphoma,
Large B-cell lymphoma with IRF4 rearrangement,
Epstein-Barr virus (EBCV)–positive diffuse large B-cell lymphoma (DLBCL), Nos,
Burkitt's Lymphoma,
Plasmablastic Lymphoma,
High-grade B-cell Lymphoma,
Primary Cutaneous Follicle Center Lymphoma,
Primary Effusion Lymphoma,
Mantle Cell Lymphoma,
Diffuse large B-cell lymphoma (DLBCL) Germinal Center B-Cell Type,
Primary Mediastinal Large B Cell Lymphoma,
T-Cell/Histiocyte-Rich Lymphoma,
ALK-Positive Large B-Cell Lymphoma,
Primary Cutaneous Diffuse Large B-Cell Lymphoma (DLBCL),
Splenic Marginal Zone Lymphoma,
Chronic Lymphocytic Leukemia,
Nodal Marginal Zone Lymphoma,
HHV8-Positive Diffuse large B-cell lymphoma (DLBCL), Nos
Lymphoplasmacytic Lymphoma,
Duodenal-Type Follicular Lymphoma
Phase 1, open-label, multicenter, dose escalation study of SRG-1505 as monotherapy in subjects with mature b-cell malignancies
EU CTIS ID: 2023-505204-34-00
What this study is testing
Human Pharmacology (Phase I)- First administration to humans
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Where it's taking place
United States
Moldova, Republic of
Ukraine
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include United States; Moldova, Republic of; Ukraine. Enter your location above to see the nearest site and check your eligibility.
BridgeMD is an information and trial-matching tool - not medical advice, and not the
study sponsor. Details come from EU CTIS; the study team decides eligibility.
BridgeMD